News Headlines

Display #
Sanofi and Lonza to build new $285 million Swiss biologics facility
Six Biotechs Facing Key FDA Decisions in March
82% of U.S. Adults Have Trouble Sleeping, finds Packaged Facts report
La Jolla’s blood pressure drug clears key study
New drugs needed to fight priority pathogens
Trump meets insurers, promises catastrophic year for Obamacare
Allergan’s New Eyepowerment Campaign Urges The Up To 33 Million Americans Suffering from Symptoms of Chronic Dry Eye to Take Action
Molecule stops fatal pediatric brain tumor
DIA EuroMeeting explores the road ahead for drug development in the EU and UK
FDA approves once-daily Qtern (dapagliflozin and saxagliptin) tablets for adults with type-2 diabetes
Alzheimer's drug prescribed off-label could pose risk for some
Bristol-Myers Squibb expands International Immuno-Oncology Network (II-ON)
Merck drug prevents serious infection after marrow transplant: study
Scientists test deep brain stimulation as potential anorexia therapy
CUBE Tech Fair welcomes spectacular speakers
Surprising Departure: Celgene President and COO “Retiring” in the Summer
Ronald E. Blaylock elected to Pfizer's Board of Directors
Buyers Remorse: Merck & Co. Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix Buy
Novartis wins CHMP nod for cancer drug combo
Cempra’s bacterial skin infection drug clears study
PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines
Another record year for Bayer - good progress with the acquisition of Monsanto
First-Ever Device for Fast and Virtually Painless Blood Draw Receives FDA Clearance
Novartis cancer drug Zykadia gets FDA priority review
Novartis drug Zykadia receives FDA Priority Review for first-line use in patients with ALK+ metastatic NSCLC
Roche Reports Death in Phase III Hemophilia Study
Medical Advertising Hall of Fame 2017
The End of the Road: NovaDel Pharma to Dissolve
Cyclacel’s leukemia drug fails in key study
Drugs similar to aspirin, ibuprofen could help treat sepsis, study suggests